Featured
Status
Health Topics
Any Category-
- Animal Diseases 1
- Bacterial Infections and Mycoses 65
- Cardiovascular Diseases 92
- Chemically-Induced Disorders 38
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities 125
- Digestive System Diseases 89
- Endocrine System Diseases 73
- Eye Diseases 16
- Female Urogenital Diseases and Pregnancy Complications 95
- Hemic and Lymphatic Diseases 117
- Immune System Diseases 126
- Male Urogenital Diseases 78
- Musculoskeletal Diseases 43
- Neoplasms 215
- Nervous System Diseases 147
- Nutritional and Metabolic Diseases 121
- Occupational Diseases 4
- Otorhinolaryngologic Diseases 20
- Parasitic Diseases 13
- Pathological Conditions, Signs and Symptoms 294
- Respiratory Tract Diseases 45
- Skin and Connective Tissue Diseases 40
- Stomatognathic Diseases 17
- Virus Diseases 68
- Wounds and Injuries 30
Search Clinical Trials
Completed
Food, Fun, & Fitness Internet Program for Girls: Outcome Evaluation (External Link)
This research will conduct an outcome evaluation on a promising web based obesity prevention program for 8-10 year old African American girls. A pilot study with 80 girls established its …
Baylor Role:
Lead Sponsor
Withdrawn
Study of Metformin With Simvastatin for Men With Prostate Carcinoma (External Link)
Men who participate in this study will take both metformin and simvastatin every day. Both drugs are pills and can be taken at home. Subjects will be asked to take …
Completed
A Pilot Project Exploring the Impact of Whole Genome Sequencing in Healthcare (External Link)
Whole genome sequencing (WGS) and whole exome sequencing (WES) services are currently available to and are being utilized by physicians and their patients in both research and clinical settings. The …
Baylor Role:
Collaborator
Completed
Human Milk Cream as a Caloric Supplement in Pre-Term Infants (External Link)
Once fortification (to either mother's or donor milk) is initiated and tolerance is established (based on clinical observation), infants will be randomized into one of two groups: to receive human …
Baylor Role:
Lead Sponsor
Active, Not Recruiting
Post-Discharge Growth of Infants Who Received Donor Human Milk Products in the Neonatal Intensive Care Unit (NICU) (External Link)
An exclusive human milk protein diet in infants less than 1250 grams birth weight has been shown to reduce the rate of necrotizing enterocolitis, a devastating intestinal disease in premature …
Baylor Role:
Lead Sponsor
Active, Not Recruiting
Administration of Donor T Cells With the Caspase-9 Suicide Gene (External Link)
If the patient is doing well after the stem cell transplant, and does not have severe GvHD, s/he will be eligible to receive the special "iCasp9" T cells from Day …
Baylor Role:
Lead Sponsor
Completed
Endobronchial Ultrasound Guided Transbronchial Needle Aspiration Performed Under General Anesthesia Versus Moderate Sedation (External Link)
The purpose of the study is to determine if there are any differences in yield or safety of Endobronchial Ultrasound-guided Transbronchial Needle Aspiration (EBUS-TBNA) (a type of bronchoscopy with biopsy) …
Baylor Role:
Lead Sponsor
Recruiting
Monitoring Chronic Obstructive Pulmonary Disease Patients at Home by a Forced Oscillation Technique Device (External Link)
The continuous progresses of medical science and technology and the improvement of life conditions have increased the life expectancy in industrialized countries: the result is the progressive population aging [UN, …
Baylor Role:
Collaborator
Completed
Safety and Immunogenicity of a Human Hookworm Candidate Vaccine With or Without Additional Adjuvant in Brazilian Adults (External Link)
Human hookworm infection is a soil-transmitted helminth infection caused by the nematode parasites Necator americanus and Ancylostoma duodenale. It is one of the most common chronic infections of humans, afflicting …
Baylor Role:
Lead Sponsor
Withdrawn
Administration of T Lymphocytes for Hodgkin's Lymphoma and Non-Hodgkin's Lymphoma (CART CD30) (External Link)
When the patient enrolls on this study, they will be assigned a dose of CD30 chimeric receptor-activated T cells. The dose level of cells that they will receive will not …
Baylor Role:
Collaborator